KDIGO 2025 clinical practice guideline for the evaluation, management, and treatment of autosomal dominant polycystic kidney disease (ADPKD): executive summary
Vicente E. Torres(Mayo Clinic), Curie Ahn(Seoul National University), Thijs R.M. Barten(Radboud University Nijmegen), Godela Brosnahan(University of Colorado Anschutz Medical Campus), Melissa A. Cadnapaphornchai(Children's Hospital of Philadelphia), Arlene B. Chapman(University of Chicago), Émilie Cornec-Le Gall(Inserm), Joost P.H. Drenth(Radboud University Nijmegen), Ron T. Gansevoort(University Medical Center Groningen), Peter C. Harris(Mayo Clinic), Tess Harris(Polycystic Kidney Disease Foundation), Shigeo Horie(Juntendo University), Max C. Liebau(University of Cologne), Michele Liew(National Patient Safety Foundation), Andrew Mallett(Townsville Hospital), Changlin Mei(Shanghai Changzheng Hospital), Djalila Mekahli(Universitair Ziekenhuis Leuven), Dwight Odland(CHDI Foundation), Albert Ong(University of Sheffield), Luiz F. Onuchic(Universidade de São Paulo), York Pei(University of Toronto), Ronald D. Perrone(Tufts University), Gopala K. Rangan(Westmead Institute for Medical Research), Brian Rayner(University of Cape Town), Roser Torrá(Puigvert Foundation), Ethan M. Balk(Brown University), Craig E. Gordon(Rhode Island Department of Health), Amy Earley, Reem A. Mustafa(University of Kansas), Olivier Devuyst(Cliniques Universitaires Saint-Luc)
Cited by 81Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis